Centiva Capital, LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Centiva Capital, LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2023$494,663
-31.4%
5,810
-36.6%
0.01%
+10.0%
Q4 2022$720,592
+47.7%
9,162
+39.0%
0.01%
+11.1%
Q3 2022$488,000
+49.7%
6,589
+31.8%
0.01%
+12.5%
Q2 2022$326,000
-24.0%
5,000
-38.1%
0.01%
-11.1%
Q4 2021$429,000
-65.9%
8,080
-57.2%
0.01%
-70.0%
Q2 2021$1,259,000
+145.4%
18,889
+308.7%
0.03%
+50.0%
Q1 2021$513,0004,6220.02%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders